Mitigating Health Risks of Prescription Drugs: Lessons From FDA Oversight of Opioid Products
JAMA
.
2019 Feb 19;321(7):651-653.
doi: 10.1001/jama.2019.0236.
Authors
Ameet Sarpatwari
1
,
Gregory Curfman
2
Affiliations
1
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
2
Deputy Editor.
PMID:
30778584
DOI:
10.1001/jama.2019.0236
No abstract available
Publication types
Editorial
Comment
MeSH terms
Analgesics, Opioid
Fentanyl*
Prescription Drug Misuse
Prescription Drugs*
Risk Evaluation and Mitigation
Substances
Analgesics, Opioid
Prescription Drugs
Fentanyl